VIR Key Financial Ratios - Vir Biotechnology, Inc.

Complete source-backed ratio history.

Historical Key Financial Ratios

Date	Current ratio	Debt/equity	ROA	ROE
2026-06-30	6.04	—	-20.72%	-25.62%
2026-03-31	7.11	—	-43.17%	-54.47%
2025-12-31	5.54	—	-43.68%	-57.23%
2025-09-30	7.25	—	-49.01%	-62.76%
2025-06-30	7.01	—	-46.14%	-58.07%
2025-03-31	6.79	—	-44.17%	-55.34%
2024-12-31	8.71	—	-37.31%	-45.37%
2024-09-30	8.94	—	-35.60%	-42.99%
2024-06-30	12.51	—	-28.93%	-33.69%
2024-03-31	12.9	—	-30.07%	-34.86%
2023-12-31	9.05	—	-32.05%	-38.68%
2023-09-30	10.72	—	-29.38%	-35.86%
2023-06-30	8.63	—	-11.68%	-14.47%
2023-03-31	4.86	—	-5.39%	-7.29%
2022-12-31	4.93	—	18.41%	24.82%
2022-09-30	7.83	—	42.39%	53.15%
2022-06-30	4.79	—	41.15%	55.22%
2022-03-31	3.66	—	42.12%	60.77%
2021-12-31	4.58	—	27.05%	36.92%
2021-09-30	4.56	—	-8.45%	-11.68%
2021-06-30	5.91	—	-28.12%	-40.33%
2021-03-31	2.75	—	-34.37%	-59.96%
2020-12-31	7.8	—	-32.51%	-41.66%
2020-09-30	11.03	—	-27.22%	-31.61%
2020-06-30	10.53	—	-32.80%	-39.11%
2020-03-31	6.69	—	-46.79%	-58.70%
2019-12-31	6.81	—	-34.11%	-41.20%
2019-09-30	7.62	—	-32.49%	48.90%
2019-06-30	—	—	—	51.67%
2018-12-31	2.95	—	—	—

Date	Current ratio	Debt/equity	ROA	ROE
2025-12-31	5.54	—	-43.68%	-57.23%
2024-12-31	8.71	—	-37.31%	-45.37%
2023-12-31	9.05	—	-32.05%	-38.68%
2022-12-31	4.93	—	18.41%	24.82%
2021-12-31	4.58	—	27.05%	36.92%
2020-12-31	7.8	—	-32.51%	-41.66%
2019-12-31	6.81	—	-34.11%	-41.20%
2018-12-31	2.95	—	-60.48%	64.68%
2017-12-31	—	—	—	101.36%